2007 tuberculosis scare

Last updated

The 2007 tuberculosis scare occurred when a personal-injury lawyer from Atlanta, Andrew "Drew" Speaker, while infected with multidrug-resistant tuberculosis (MDR-TB), flew on several international flights bound for France, Greece, Italy, Czech Republic and Canada, before returning to the United States. [1] [2] The Centers for Disease Control and Prevention believed at the time that Speaker was suffering from extensively drug-resistant tuberculosis (XDR-TB), but failed to inform Speaker of this worsened sickness before his travels abroad. The incident sparked a debate in Congress on the failure of federal customs agents to stop him. [2] Upon Speaker's return to the United States, the CDC placed him under involuntary isolation (similar to quarantine) using a provision of the Public Health Service Act. [3] With this action, Speaker became the first individual subjected to a CDC isolation order since 1963. [4]

Contents

Background

In January 2007, Speaker suffered a fall and went to the doctor, concerned that he had bruised a rib. Doctors X-rayed his chest and found an abnormality that required further testing. [5] Andrew Speaker was suspected of having TB when a positive PPD test came back on March 2, 2007. His third CT scan was done on March 3, 2007, and a bronchoscopy was done on March 8, 2007. After 18 days of incubation the isolate was sent to CDC for confirmation of his susceptibility results that were done by the Georgia Department of Human Resources (DHR).[ citation needed ]

On March 28, 2007, his doctors and the health department believed the TB strain Speaker had was a resistant one and communicated this to the CDC. On May 1 the apparent MDR TB infection was discussed with the CDC lab by his doctors and they discussed discontinuing the treatment he was on at that time. On May 9 the suspicion of MDR TB was confirmed. A meeting was held with Fulton County Health Officials, his doctors, his fiancée and his father and father-in-law on May 10, 2007. At this time he was told that he was not contagious and not a threat to anyone but that he would need to go to Denver for treatment. [5] It would take a few weeks to arrange this. He was advised, or according to some accounts strongly recommended, not to travel. [5]

Travel sequence

On May 12, 2007, Speaker flew from the U.S. to Paris. On May 14, he flew on to Athens and, two days later, flew to the Aegean holiday island of Santorini for his wedding. Speaker then flew to Rome for his honeymoon.

Doctors say that only after Speaker left the United States did they realize he likely had XDR-TB. Speaker says that he was informed of MDR TB before leaving the country, and that while officials preferred him not to fly, they said that he was not a threat and was not required to wear a mask. [6] Once Speaker was in Europe, however, test results showed his strain of tuberculosis was even rarer than originally thought, leading public health officials to try to persuade Speaker to turn himself in to Italian health authorities. [7] [8] The CDC informed him that there were no options for the CDC to get him home, and that he would have to arrange private transportation. Speaker instead flew by commercial jet to Prague and then on to Montréal. [9] Both Speaker and his new wife claimed that, had they been offered transport, they would have accepted it and would have waited in Rome. [10] Speaker has also said that the CDC told him they were going to send officials to put him in Italian quarantine for up to two years, and that he was not told special transportation was arranged. [10]

Once in Montréal, Speaker rented a car and drove across the Canada–United States border. A Customs and Border Protection Officer failed to detain him at the frontier, disregarding a warning after he had passed Speaker's passport through the Treasury Enforcement Communications System (TECS) [2] to hold the traveler, wear a protective mask when dealing with him, and call health authorities because he "did not look sick". [11]

Flight itinerary

According to the CDC, Speaker flew on the following flights: [12]

Flight Itinerary of U.S. Traveler
AirlinesFlight#AircraftDateDepartingScheduled DepartureCalculated Scheduled DurationArrivingNumber of PassengersPatient Seat Row Number
Air France / Delta 385 / 8517 Boeing 747-400 2007-05-12 Atlanta, Georgia 8:45 PM Local8 Hr 27 Min Paris, France 43330
Air France1232 Airbus A320 2007-05-14Paris, France7:35 AM Local3 Hr 11 Min Athens, Greece not more than 172unknown
Olympic Air 560 ATR 72-202 2007-05-16Athens, Greece7:25 PM Local0 Hr 40 Min Thira Island, Greece not more than 74unknown
Olympic Air655ATR 72-2022007-05-21 Mykonos Island, Greece 1:45 PM Local0 Hr 40 MinAthens, Greecenot more than 74unknown
Olympic Air239 Boeing 737-400 2007-05-21Athens, Greece5:30 PM Local2 Hr 05 Min Rome, Italy not more than 168unknown
Czech Airlines 727Boeing 737-4002007-05-24Rome, Italy8:50 AM Local1 Hr 55 Min Prague, Czech Republic not more than 168unknown
Czech Airlines0104 Airbus A310 2007-05-24Prague, Czech Republic12:25 PM Local8 Hr 25 Min Montreal, Canada 19112

Tuberculosis case notes

On May 31, 2007, Speaker was moved from Grady Memorial Hospital in Atlanta to the National Jewish Medical and Research Center in Denver, Colorado, for further treatment. [13]

It was reported that Speaker's father-in-law, Robert C. Cooksey, works for the Centers for Disease Control and Prevention and is a microbiologist who has conducted research on tuberculosis, according to his CDC biography posted on the agency's Web site. [14]

Wearing a medical mask, Speaker was interviewed by Diane Sawyer on the June 1 edition of the American talk show Good Morning America on ABC and apologized to all passengers, explaining that he had not intended to endanger them. [15]

According to an interview on Larry King Live , Speaker said that he had not been told that there was any risk of transmitting the disease to others, nor did the May 10 letter recommending against his travel state this, which Speaker in any case had not received before leaving May 14. His wife, with whom he lived for five months without precautions, remained uninfected.[ citation needed ]

New diagnosis

On July 4, 2007, the National Jewish Medical and Research Center announced, and the CDC confirmed, that Mr. Speaker's earlier diagnosis was incorrect and that he instead had multidrug-resistant tuberculosis (MDR-TB), a more treatable form of tuberculosis. [16]

Isolation and law

Before a Congressional hearing, Speaker and his father played audio recordings from CDC and Fulton County health officials which say he was not a danger to others. He asked such questions on five recordings repeatedly and was given the same answers even after stating on two recordings that he was going out of the country and the CDC later admitted they were aware and waited until he had already left before taking further actions.[ citation needed ]

Speaker was in New York when the CDC served him with an isolation order but CDC director Julie Gerberding stated that the government was legally constrained prior to that order. The federal statute granting quarantine authority allows isolation or quarantine but only for individuals coming into the country from a foreign country or territory. [17]

Georgia TB law may have required Speaker to be confined for two weeks and only allowed travel for medical appointments. [18] A court confinement order can isolate a patient only after the infected patient ignores medical advice. This method can be overridden by a declaration of public health emergency by the governor of Georgia.

In 2007, seven Canadians and two Czechs sued Speaker in Montreal Superior Court; eight of the plaintiffs were on the same flight as Andrew Speaker and one was related to one of the passengers. [19]

See also

Related Research Articles

<span class="mw-page-title-main">Tuberculosis</span> Infectious disease

Tuberculosis (TB), also known colloquially as the "white death", or historically as consumption, is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs, but it can also affect other parts of the body. Most infections show no symptoms, in which case it is known as latent tuberculosis. Around 10% of latent infections progress to active disease which, if left untreated, kill about half of those affected. Typical symptoms of active TB are chronic cough with blood-containing mucus, fever, night sweats, and weight loss. Infection of other organs can cause a wide range of symptoms.

<span class="mw-page-title-main">Tuberculosis management</span>

Tuberculosis management describes the techniques and procedures utilized for treating tuberculosis (TB) or simply a treatment plan for TB.

Latent tuberculosis (LTB), also called latent tuberculosis infection (LTBI) is when a person is infected with Mycobacterium tuberculosis, but does not have active tuberculosis (TB). Active tuberculosis can be contagious while latent tuberculosis is not, and it is therefore not possible to get TB from someone with latent tuberculosis. The main risk is that approximately 10% of these people will go on to develop active tuberculosis. This is particularly true, and there is added risk, in particular situations such as medication that suppresses the immune system or advancing age.

TB Alliance is a not-for-profit product development partnership (PDP) dedicated to the discovery and development of new, faster-acting and affordable tuberculosis (TB) medicines. Since its inception in 2000, TB Alliance has worked to grow the field of available treatments for TB and now manages the largest pipeline of new TB drugs in history. It was founded in Cape Town, South Africa, and has since expanded. It is headquartered in New York City and has a regional office in Pretoria.

<span class="mw-page-title-main">Extensively drug-resistant tuberculosis</span> Tuberculosis that is resistant to the most effective drugs

Extensively drug-resistant tuberculosis (XDR-TB) is a form of tuberculosis caused by bacteria that are resistant to some of the most effective anti-TB drugs. XDR-TB strains have arisen after the mismanagement of individuals with multidrug-resistant TB (MDR-TB).

<span class="mw-page-title-main">Multidrug-resistant tuberculosis</span> Medical condition

Multidrug-resistant tuberculosis (MDR-TB) is a form of tuberculosis (TB) infection caused by bacteria that are resistant to treatment with at least two of the most powerful first-line anti-TB medications (drugs): isoniazid and rifampicin. Some forms of TB are also resistant to second-line medications, and are called extensively drug-resistant TB (XDR-TB).

The National Tuberculosis Elimination Programme (NTEP), earlier known as the Revised National Tuberculosis Control Programme (RNTCP), is the Public Health initiative of the Government of India that organizes its anti-Tuberculosis efforts. It functions as a flagship component of the National Health Mission (NHM) and provides technical and managerial leadership to anti-tuberculosis activities in the country. As per the National Strategic Plan 2017–25, the program has a vision of achieving a "TB free India",with a strategies under the broad themes of "Prevent, Detect,Treat and Build pillars for universal coverage and social protection". The program provides, various free of cost, quality tuberculosis diagnosis and treatment services across the country through the government health system.

<span class="mw-page-title-main">Bedaquiline</span> Medication used to treat tuberculosis

Bedaquiline, sold under the brand name Sirturo, is a medication used for the treatment of active tuberculosis. Specifically, it is used to treat multi-drug-resistant tuberculosis along with other medications for tuberculosis. It is taken by mouth.

<span class="mw-page-title-main">Pretomanid</span> Chemical compound

Pretomanid is an antibiotic medication used for the treatment of multi-drug-resistant tuberculosis affecting the lungs. It is generally used together with bedaquiline and linezolid. It is taken by mouth.

<span class="mw-page-title-main">Tuberculosis in China</span>

Tuberculosis is a serious public health problem in China. China has the world's third largest cases of tuberculosis, but progress in tuberculosis control was slow during the 1990s. Detection of tuberculosis had stagnated at around 30% of the estimated total of new cases, and multidrug-resistant tuberculosis was a major problem. These signs of inadequate tuberculosis control can be linked to a malfunctioning health system. The spread of severe acute respiratory syndrome (SARS) in 2003, brought to light substantial weaknesses in the country's public health system. After the government realized the impact that the SARS outbreak had on the country, they increased leadership in their health department. After the SARS epidemic was brought under control, the government increased its commitment and leadership to tackle public health problems and, among other efforts, increased public health funding, revised laws that concerned the control of infectious diseases, implemented the world's largest internet-based disease reporting system to improve transparency, reach and speed, and started a program to rebuild local public health facilities and national infrastructure.

The Xpert MTB/RIF is a cartridge-based nucleic acid amplification test (NAAT) for simultaneous rapid tuberculosis diagnosis and rapid antibiotic sensitivity test. It is an automated diagnostic test that can identify Mycobacterium tuberculosis (MTB) DNA and resistance to rifampicin (RIF). It was co-developed by the laboratory of Professor David Alland at the University of Medicine and Dentistry of New Jersey (UMDNJ), Cepheid Inc. and Foundation for Innovative New Diagnostics, with additional financial support from the US National Institutes of Health (NIH).

Totally drug-resistant tuberculosis (TDR-TB) is a generic term for tuberculosis strains that are resistant to a wider range of drugs than strains classified as extensively drug-resistant tuberculosis. Extensively drug resistant tuberculosis is tuberculosis that is resistant to isoniazid and rifampicin, any fluoroquinolone, and any of the three second line injectable TB drugs. TDR-TB has been identified in three countries; India, Iran, and Italy. The term was first presented in 2006, in which it showed that TB was resistant to many second line drugs and possibly all the medicines used to treat the disease. Lack of testing made it unclear which drugs the TDR-TB were resistant to.

<span class="mw-page-title-main">Tuberculosis in India</span> Health issue in India

Tuberculosis in India is a major health problem, causing about 220,000 deaths every year. In 2020, the Indian government made statements to eliminate tuberculosis from the country by 2025 through its National TB Elimination Program. Interventions in this program include major investment in health care, providing supplemental nutrition credit through the Nikshay Poshan Yojana, organizing a national epidemiological survey for tuberculosis, and organizing a national campaign to tie together the Indian government and private health infrastructure for the goal of eliminating the disease.

Operation ASHA(OpASHA) is a non-profit organization (NGO) founded in 2006 to bring tuberculosis (TB) treatment at economically feasible rates to disadvantaged communities. The organization's primary work is to detect and cure TB, as well as to prevent and treat multidrug-resistant tuberculosis (MDR-TB) in India and Cambodia. Operation ASHA specializes in last-mile connectivity, bridging the gap between government medicine distribution centers and the communities of patients to deliver treatment at the doorsteps of the under-served. In addition to detecting and curing TB, OpASHA's community health workers also educate the community about TB and its symptoms thereby helping to reduce the stigma there is regarding the disease. In addition to TB, Operation ASHA's model and technology has been used in many other diseases such as diabetes, hemophilia and mental health.

<span class="mw-page-title-main">Prisons in Russia</span> Prison system in Russia

Prisons in Russia consist of four types of facilities: pre-trial institutions; educative or juvenile colonies; corrective colonies; and prisons.

<span class="mw-page-title-main">Ebola virus cases in the United States</span>

Four laboratory-confirmed cases of Ebola virus disease occurred in the United States in 2014. Eleven cases were reported, including these four cases and seven cases medically evacuated from other countries. The first was reported in September 2014. Nine of the people contracted the disease outside the US and traveled into the country, either as regular airline passengers or as medical evacuees; of those nine, two died. Two people contracted Ebola in the United States. Both were nurses who treated an Ebola patient; both recovered.

Zarir Udwadia is an Indian pulmonologist and researcher. His work on drug resistant tuberculosis has led to improvements in India's National Tuberculosis Control Programme. Udwadia was the only Indian invited by the WHO to be part of the TB ‘Guidelines Group’, which formulated the 4th edition of the TB Guidelines, published in 2010. He was also the only doctor to be named among India's best strategists.

Jaime Bayona García is a Peruvian physician who focuses on public health and he has become a specialist in studying the epidemiology of tuberculosis. He is also known for his case studies on HIV/AIDS in Peru and other developing countries. Dr. Bayona has also done work on how public health systems should improve, in terms of providing the best approach to help the sick that cannot afford health care.

Phumeza Tisile is a healthcare activist from South Africa who advocates for making tuberculosis medication inexpensive and widely available. Tisile survived extensively drug-resistant tuberculosis (XDR-TB), enduring three years and 8 months of treatment. Tisile's initial misdiagnoses led to months of incorrect treatment, which caused her to become deaf. As an activist, Tisile advocates for improved access to tuberculosis (TB) diagnosis and treatment, improved counseling for patients, research into better treatments, and elimination of TB stigma.

References

  1. ↑ Border security scrutinized after TB patient slips in Archived 2008-03-08 at the Wayback Machine , CNN.com
  2. 1 2 3 Emily Brown and Jeff Bliss, "Border Agents Failed to Stop Man With Tuberculosis" (Update4).
  3. ↑ "Fact Sheet on Isolation and Quarantine". Centers for Disease Control and Prevention. Retrieved June 3, 2007.
  4. ↑ "Odd twist in TB alert: Patient is TB researcher's son-in-law". CIDRAP. May 31, 2007. Archived from the original on June 3, 2007. Retrieved June 2, 2007.
  5. 1 2 3 "A Timeline of Andrew Speaker's Infection, June, 2007". NPR. Retrieved April 16, 2016.
  6. ↑ Andrew Speaker Says He's Being Unfairly Attacked by Eve Conant, Newsweek, 2 Jun 2007. Accessed 2009-04-30. Archived 2009-05-21.
  7. ↑ "TB patient insists he was never banned from travel". CNN. June 7, 2007
  8. ↑ "CDC Stands by Decision to Sound Public Alarm". ABC News. July 4, 2007
  9. ↑ Park, Alice. "The TB Scare: A Broken System?" Time. May 31, 2007.
  10. 1 2 Mike McPhee, TB patient apologizes Denver Post. June 1, 2007. Accessed 2009-04-30. Archived 2009-05-21.
  11. ↑ "Border agent fired after allowing TB patient into country". Fox News. Archived from the original on July 19, 2012. Retrieved June 11, 2007.
  12. ↑ "Flight Itinerary of U.S. Traveler with Extensively Drug–Resistant Tuberculosis (XDR TB) (May 30, 2007)". Cdc.gov. Archived from the original on October 12, 2008. Retrieved November 8, 2008.
  13. ↑ "Foxnews.com: TB Patient moved to Denver hospital, May 31, 2007". Foxnews.com. May 31, 2007. Archived from the original on October 2, 2008. Retrieved November 8, 2008.
  14. ↑ "CNN web site: TB patient's name released; father-in-law works at CDC". Cnn.com. Archived from the original on March 8, 2008. Retrieved November 8, 2008.
  15. ↑ "ABCNews.com: TB Patient: "I Really Believed I Wasn't Putting People at Risk" June 1, 2007". Abcnews.go.com. Archived from the original on September 29, 2008. Retrieved November 8, 2008.
  16. ↑ "Doctors: TB traveler's diagnosis more treatable than thought". CNN. July 4, 2007. Archived from the original on July 12, 2007. Retrieved July 4, 2007.
  17. ↑ "The Legal Questions Behind the TB Case". Law.com. Retrieved June 8, 2007.
  18. ↑ "TB patient travel may have been illegal". Physorg.com. Archived from the original on August 26, 2007. Retrieved July 18, 2007.
  19. ↑ Plane passengers sue TB patient, CNN (July 13, 2007).
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.